The information is used to measure, survey and compare aspects of CF and its treatment in participating countries, to deepen our understanding of CF, to improve standards of care, to provide data for epidemiological research and to facilitate public health planning.
The Registry’s database contains data from over 54,000 individuals with cystic fibrosis.
It includes information from 40 participating countries.
The database holds longitudinal data spanning from 2008 to 2025.
Project to enrich the ECFSPR with longitudinal quantitative structural lung data from chest computed tomography (CT) scans.
The European Cystic Fibrosis Society (ECFS), in cooperation with the ECFS Patient Registry (ECFSPR), is supporting Cystic Fibrosis (CF) patient registries for low- and middle-income countries (LMICs) outside of the WHO European Region.
Project dedicated to newborn screening for cystic fibrosis. When a newborn screening result is positive, but cystic fibrosis is not confirmed by other methods.
Project on monitoring new medicines that must be monitored in pharmacovigilance studies (PMV) in accordance with the rules of the European Medicines Agency (EMA).
We invite applications from researchers, industry representatives and pharmaceutical partners seeking to leverage these valuable data for scientific research purposes.
Discover ECFSPR in 2023 through insights from our Chair and Director, reports on last year’s achievements.
Thanks to our valued partners and sponsors, we can advance research and improve outcomes.
Together, we make a difference!